Elysium is a health startup with a mission to help people live healthier, longer. The company was started by Dr. Leonard Guarente who works as the chief scientist of the company and as the director of the Paul F. Glenn Center for Biology of Aging Research at MIT in addition to his duties at Elysium. During his career, Dr. Guarente has conducted significant research on the genetic and molecular causes of aging.
Elysium Health sells a supplement called Basis. This supplement works to increase levels of the coenzyme NAD+ in our cells. NAD+ is essential to many of our cellular functions like energy creation, circadian rhythms, and DNA protection. But as we age, our levels of NAD+ decline and those functions break down.
Basis is clinically proven to increase levels of NAD+ by an average of 40% in humans, supporting your cellular health as a result. Elysium Health performed a clinical trial in 2016 to ensure that Basis works as intended and frequently puts the supplement through third-party quality testing. The results of the trial showed that taking Basis daily over the course of four weeks increased levels of NAD+ in humans by an average of 40%. The increase in NAD+ levels was maintained at eight weeks. The results of the study trial were published in the science journal npj: Aging and Mechanisms of Disease.
— Elysium Health (@ElysiumHQ) April 8, 2018
To purchase Basis, visit Elysium Health’s website. The company offers individual jars of Basis for $60, which contain about a month’s worth of supplement, and monthly subscriptions ranging from $40-50 per month, depending on the length of the subscription.
Elysium Health is also developing new products that focus on the microbiome, cognitive health, skin health, muscle function, and circadian rhythms. These products are in various stages of pre-clinical and clinical trials.
More information on Elysium Health, the company’s team of scientists, and the science behind Basis can be found on Elysium’s website.